Latest papers

Association between the Pulmonary Embolism Severity Index (PESI) and short-term clinical deterioration.

[Guidelines for the management of grown-up congenital heart disease (new version 2010)].

Monitoring the ill: Is this another measurement or will it change outcomes?

Potassium level changes - arrhythmia contributing factor in chronic kidney disease patients.

A combined gene and cell therapy approach for restoration of conduction.

The novel roles of four and a half LIM proteins 1 and 2 in the cardiovascular system.

ECG of the month. Bigeminal rhythm VIII. Sinus rhythm with normal antegrade atrioventricular (A-V) conduction and slow retrograde conduction back to the atria, producing atrial reentry or echo complexes and suggesting dual A-V nodal pathways or an accessory A-V pathway that conducts slowly from the ventricles to the atria.

Cardiorespiratory instability before and after implementing an integrated monitoring system.

Sudden cardiac death and implantable cardioverter-defibrillators.

Antiarrhythmic effect mediated by κ-opioid receptor is associated with Cx43 stabilization.

[Subcutaneous implantable cardioverter defibrillator: an alternative solution?].

Stem cell cardiac repair and arrhythmias.

Asymptomatic rhythm and conduction abnormalities in children with acute rheumatic fever: 24-hour electrocardiography study.

[Heart rhythm disturbances and their treatment according to recent recommendations].

[Electrocardiography with R test is effective for diagnosis of arrhythmia in patients who fall].

[42-year-old patient with palpitations].

[Vascular calcification in chronic kidney disease].

[Present trends and controversies in the use of beta-blockers in cardiovascular diseases].

Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy.

Low risk for arrhythmic events in asymptomatic patients with drug-induced type 1 ECG. Do patients with drug-induced Brugada type ECG have poor prognosis? (Con).